Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by newdaydawningon Sep 26, 2019 5:07pm

217 Views

Post# 30168161

Mackie has zero credibility vis a vis TLT

As a would-be investor in Theralase, I would not given any credence to Mackie's research report.

Mackie no doubt had a strong hand in butchering the TLT SP to get this best possible deal for their uber-rich clients.

After destroying TLT's value, Mackie now comes out and says the company is actually worth almost 4 times its current price.

But if the company is really worth 80 cents, why is Mackie selling late today at 22.5 cents?

These financiers cannot be trusted. Any report out of Maxim would be similarily suspect.

Bullboard Posts

3 Mid-Sized Stocks to Consider This Season